Davis, CA, United States of America

Maroof Adil

This inventor holds 6 USPTO granted patents and 14 published patent applications. Top assignee: Scribe Therapeutics Inc.. Active years: 2022-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maroof Adil. Retrieved from https://idiyas.com/inventor/maroof-adil

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 6 

% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 4

Forward Citations = 25(Granted Patents)


Company Filing History:


Years Active: 2022-2026

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Maroof Adil: Innovator in Immunotherapy

Introduction

Maroof Adil is a prominent inventor based in Davis, CA (US). He has made significant contributions to the field of immunotherapy, holding a total of 6 patents. His work focuses on developing innovative systems and methods that enhance the effectiveness of immunotherapy treatments.

Latest Patents

Maroof Adil's latest patents include groundbreaking advancements in immunotherapy. One of his notable inventions is related to "Compositions and methods for use in immunotherapy." This patent describes CasX:gNA systems, which comprise CasX proteins and guide nucleic acids (gNAs). These systems are designed for modifying cell genes that encode proteins involved in antigen processing, presentation, recognition, and response. The methods outlined in this patent also include producing and utilizing populations of cells with these modified genes. Additionally, some modified cells express chimeric antigen receptors (CAR) or engineered T cell receptors (TCR), making them valuable for immunotherapy applications.

Another significant patent focuses on "Guide scaffolds." This invention provides reference guide nucleic acid scaffolds and their variants, which can bind to engineered proteins containing a RuvC cleavage domain. The variants of these scaffolds exhibit improved characteristics compared to the reference sequences, showcasing Maroof's commitment to enhancing the functionality of nucleic acid scaffolds.

Career Highlights

Maroof Adil is currently associated with Scribe Therapeutics Inc., where he continues to push the boundaries of innovation in the field of gene editing and immunotherapy. His work has positioned him as a key player in the development of advanced therapeutic solutions.

Collaborations

Maroof collaborates with talented individuals such as Hannah Spinner and Benjamin Oakes, contributing to a dynamic research environment that fosters innovation and creativity.

Conclusion

Maroof Adil's contributions to immunotherapy through his patents and collaborative efforts highlight his role as a leading inventor in the field. His work not only advances scientific knowledge but also has the potential to significantly impact patient care and treatment outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…